|
PELO expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.51600000003671E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.36189999949887E-07 |
| Normal-vs-Stage2 |
5.744300E-02 |
| Normal-vs-Stage3 |
8.276200E-01 |
| Normal-vs-Stage4 |
7.176600E-01 |
| Stage1-vs-Stage2 |
3.106800E-01 |
| Stage1-vs-Stage3 |
2.710100E-02 |
| Stage1-vs-Stage4 |
9.860400E-02 |
| Stage2-vs-Stage3 |
2.732000E-01 |
| Stage2-vs-Stage4 |
4.574600E-01 |
| Stage3-vs-Stage4 |
8.558200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81539999999369E-06 |
| Normal-vs-AfricanAmerican |
1.756380E-03 |
| Normal-vs-Asian |
9.245800E-01 |
| Caucasian-vs-AfricanAmerican |
6.270800E-01 |
| Caucasian-vs-Asian |
1.193580E-01 |
| AfricanAmerican-vs-Asian |
2.063200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.83050000104978E-08 |
| Normal-vs-Female |
4.805600E-01 |
| Male-vs-Female |
3.39220000000751E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.616900E-03 |
| Normal-vs-Extreme_Weight |
1.56169999998568E-06 |
| Normal-vs-Obese |
3.742400E-03 |
| Normal-vs-Extreme_Obese |
1.96024999999933E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.074200E-01 |
| Normal_Weight-vs-Obese |
6.775400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.283200E-01 |
| Extreme_Weight-vs-Obese |
1.447200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.874000E-01 |
| Obese-vs-Extreme_Obese |
1.123020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.450200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.568700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.83040000045764E-07 |
| Normal-vs-Age(81-100Yrs) |
6.876500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.566000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.019000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.367970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.717500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.477800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.741200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.82110051669827E-10 |
| Normal-VS-Type2 PRCC |
1.566770E-01 |
| Normal-VS-KIRP CIMP |
5.716800E-01 |
| Normal-VS-Unclassified PRCC |
1.518570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.837400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.419700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.462000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.583000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.312800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.917430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.787900E-02 |
| Normal-vs-N1 |
9.611200E-01 |
| Normal-vs-N2 |
8.688000E-01 |
| N0-vs-N1 |
2.087000E-01 |
| N0-vs-N2 |
4.374400E-01 |
| N1-vs-N2 |
8.612800E-01 |
|
|
